[Chronic coronary syndrome in patients with non-obstructive coronary arteries].
ARK, P., S, K., A, E., LO, J., T, E., EH, C., & EN, H. (2026). [Chronic coronary syndrome in patients with non-obstructive coronary arteries].. Ugeskrift for laeger. https://doi.org/10.61409/V09250724
ARK P, S K, A E, LO J, T E, EH C, et al. [Chronic coronary syndrome in patients with non-obstructive coronary arteries].. Ugeskrift for laeger. 2026; doi: 10.61409/V09250724
ARK P, S K, A E, et al. [Chronic coronary syndrome in patients with non-obstructive coronary arteries].[J]. Ugeskrift for laeger. 2026. DOI: 10.61409/V09250724.
@article{ark2026,
author = {Pedersen ARK and Karim S and Eftekhari A and Jensen LO and Engstrøm T and Christiansen EH and Holck EN},
title = {[Chronic coronary syndrome in patients with non-obstructive coronary arteries].},
journal = {Ugeskrift for laeger},
year = {2026},
doi = {10.61409/V09250724},
note = {PMID: 42261612},
}
TY - JOUR AU - Pedersen ARK AU - Karim S AU - Eftekhari A AU - Jensen LO AU - Engstrøm T AU - Christiansen EH AU - Holck EN TI - [Chronic coronary syndrome in patients with non-obstructive coronary arteries]. T2 - Ugeskrift for laeger PY - 2026 DO - 10.61409/V09250724 AN - PMID:42261612 ER -
Chronic coronary syndrome is a common cause of chest pain. Ischaemia with non-obstructive coronary arteries (INOCA) is underdiagnosed and more frequent in women. Patients with INOCA have a lower quality of life and a higher risk of major adverse cardiac events. Symptoms arise from endothelial dysfunction, microvascular disease, vasospastic disease or a combination. Invasive functional testing is important to secure the diagnosis and endotype of the patient. This review finds that the treatment is both pharmacological and non-pharmacological and is guided by endotype of INOCA and has shown improved quality of life.